SCHEMBL6945814

SCHEMBL6945814

CO[C@H](Cc1ccccc1)OC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1cccc(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 4/20 0.42
CACNA1B Q00975 6/20 0.39
CACNA1C Q13936 5/20 0.39
CACNA1F O60840 4/20 0.39
CACNA1D Q01668 4/20 0.39
CACNA1S Q13698 4/20 0.39
CYP2C9 P11712 6/20 0.39
CYP1A2 P05177 6/20 0.39
CYP3A4 P08684 5/20 0.39
CYP2C19 P33261 5/20 0.39
ADORA3 P0DMS8 5/20 0.39
KMT2A Q03164 4/20 0.39
ABCB11 O95342 4/20 0.39
SCN5A Q14524 4/20 0.39
CYP2D6 P10635 3/20 0.39
MEN1 O00255 3/20 0.39
KCNH2 Q12809 3/20 0.39
NR3C1 P04150 3/20 0.39
PDE4D Q08499 3/20 0.39
TBXA2R P21731 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6945821 1.00 NR1I2 (0.42) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6945809 0.97 NR1I2 (0.44) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6953639 0.80 GAA (0.45) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6945825 0.79 CACNA1F (0.47) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6942347 0.79 CACNA1F (0.47) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6942336 0.79 CACNA1F (0.47) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL6945817 0.79 ALOX15 (0.51) NR1I2CACNA1BCYP2C9CYP1A2CYP3A4
SCHEMBL7884089 0.77 NR1I2 (0.59) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D
SCHEMBL9235442 0.76 CACNA1B (0.46) NR1I2CACNA1BCYP2C9CYP1A2CYP3A4
SCHEMBL6942333 0.76 CACNA1F (0.49) NR1I2CACNA1BCACNA1CCACNA1FCACNA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657431-B1 4-Phenyl-3-substituted 1,4-dihydropyridine esters with cerebral activity BAYER AG (DE) 2003-02-19 EP claimed
US-6066655-A FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, IN PARTICULAR AS CEREBRAL THERAPEUTICS BAYER AKTIENGESELLSCHAFT (DE) 2000-05-23 US disclosed
US-5731333-A LEARNING AND MEMORY ENHANCEMENT, ANTIDEPRESSANTS BAYER AKTIENGESELLSCHAFT (DE) 1998-03-24 US disclosed